SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 188 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $14,304 | -71.8% | 10,919 | -24.8% | 0.00% | – |
| Q4 2022 | $50,685 | -20.8% | 14,523 | +19.5% | 0.00% | – |
| Q3 2022 | $64,000 | +39.1% | 12,152 | +5.9% | 0.00% | – |
| Q2 2022 | $46,000 | -27.0% | 11,480 | +7.5% | 0.00% | – |
| Q1 2022 | $63,000 | -36.4% | 10,684 | -15.8% | 0.00% | – |
| Q4 2021 | $99,000 | -94.2% | 12,684 | -92.9% | 0.00% | -100.0% |
| Q3 2021 | $1,704,000 | -49.6% | 178,353 | -38.1% | 0.00% | -50.0% |
| Q2 2021 | $3,381,000 | +10.2% | 288,307 | +5.7% | 0.00% | 0.0% |
| Q1 2021 | $3,069,000 | -23.5% | 272,755 | +10.3% | 0.00% | -33.3% |
| Q4 2020 | $4,010,000 | +40.5% | 247,347 | -16.0% | 0.00% | +50.0% |
| Q3 2020 | $2,855,000 | +1741.9% | 294,469 | +1965.3% | 0.00% | – |
| Q2 2020 | $155,000 | +868.8% | 14,258 | +522.9% | 0.00% | – |
| Q1 2020 | $16,000 | -88.5% | 2,289 | -86.3% | 0.00% | – |
| Q4 2019 | $139,000 | -40.6% | 16,702 | -35.5% | 0.00% | – |
| Q3 2019 | $234,000 | +82.8% | 25,881 | +119.1% | 0.00% | – |
| Q2 2019 | $128,000 | +509.5% | 11,813 | +438.2% | 0.00% | – |
| Q1 2019 | $21,000 | -48.8% | 2,195 | -39.5% | 0.00% | – |
| Q4 2018 | $41,000 | -37.9% | 3,627 | -8.7% | 0.00% | – |
| Q3 2018 | $66,000 | +17.9% | 3,971 | -0.5% | 0.00% | – |
| Q2 2018 | $56,000 | -94.5% | 3,991 | -92.6% | 0.00% | -100.0% |
| Q1 2018 | $1,020,000 | +541.5% | 53,638 | +454.2% | 0.00% | – |
| Q4 2017 | $159,000 | +30.3% | 9,679 | +19.5% | 0.00% | – |
| Q3 2017 | $122,000 | +454.5% | 8,101 | +223.4% | 0.00% | – |
| Q2 2017 | $22,000 | +1000.0% | 2,505 | +708.1% | 0.00% | – |
| Q1 2017 | $2,000 | +100.0% | 310 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 310 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -50.0% | 310 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 310 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -66.7% | 310 | -53.2% | 0.00% | – |
| Q4 2015 | $6,000 | -98.9% | 663 | -98.7% | 0.00% | -100.0% |
| Q2 2015 | $556,000 | -40.1% | 50,117 | -15.3% | 0.00% | 0.0% |
| Q1 2015 | $928,000 | +32.4% | 59,145 | +28.4% | 0.00% | 0.0% |
| Q4 2014 | $701,000 | +28.6% | 46,048 | -9.0% | 0.00% | 0.0% |
| Q3 2014 | $545,000 | -41.2% | 50,580 | -16.7% | 0.00% | 0.0% |
| Q2 2014 | $927,000 | +18.2% | 60,700 | +40.1% | 0.00% | 0.0% |
| Q1 2014 | $784,000 | +53.4% | 43,340 | -11.0% | 0.00% | 0.0% |
| Q3 2013 | $511,000 | – | 48,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |